The doses from AstraZeneca are waiting for trial results in the US, while countries that authorised the vaccine beg to have them.
Employees work in a lab at Emergent Biosolutions, which is manufacturing vaccines for AstraZeneca and Johnson & Johnson on February 8, 2021 in Baltimore, Maryland. There are millions of doses in the building which are awaiting FDA approval to be distributed. (Photo by Michael Robinson Chavez/The Washington Post via Getty Images)
©2019 New York Times News Service